An investigation of levetiracetam in Alzheimer's disease (ILiAD): a double-blind, placebo-controlled, randomised crossover proof of concept study - Sen, A; Akinola, M; Tai, XY; Symmonds, M; Davis Jones, G; Mura, S; Galloway, J; Hallam, A; Chan, JYC; Koychev, I; Butler, C; Geddes, J; et al. (Trials, 2021)